Creating personalized 3D models of pancreatic neuroendocrine tumors

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to develop personalized 3D preclinical models of pancreatic neuroendocrine tumors (PanNETs) using surgical specimens from patients. The models will help researchers understand the mechanisms of disease progression and facilitate drug testing. By replicating the tumor's complex biology and microenvironment, the study seeks to address the current lack of effective preclinical models for PanNETs. The research will focus on patients undergoing surgical resection for non-functioning PanNETs, ensuring that the models are tailored to individual patient characteristics.

Why it matters

Who can join: the full rules

Inclusion criteria:

* patients who undergo pancreatic surgical resection for non-functioning pancreatic neuroendocrine tumor
* age ≥ 18 years
* informed consent

Exclusion criteria:

* non-pancreatic neuroendocrine tumor histological diagnosis
* age \< 18 years

Where it's running

• IRCCS San Raffele Institute
  Milan, Mi, Italy Recruiting

Study contacts

• Study coordinator: Massimo Falconi, Professor
• Email: falconi.massimo@hsr.it
• Phone: 0039 022643 6046

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• AI-guided decision support for managing pancreatic conditions

  This project will test an AI tool that reads contrast-enhanced CT scans to help doctors decide whether people with suspected pancreatic disease need surgery, close monitoring, or routine follow-up.

  Recruiting Changhai Hospital · Shanghai · NCT07439757

• Laparoscopic versus open pancreaticoduodenectomy outcomes

  This trial will test whether laparoscopic (keyhole) pancreaticoduodenectomy leads to fewer complications and faster recovery than open pancreaticoduodenectomy in adults with resectable pancreatic or periampullary tumors.

  Recruiting Minia University · Minya, Minya Governorate · NCT07328607

• Near‑total debulking surgery versus non‑surgical management for metastatic pancreatic neuroendocrine tumours

  This study will test whether removing most of the tumour (near‑total debulking surgery) helps adults with stage 4 non‑functional pancreatic neuroendocrine tumours live longer or feel better compared with not doing debulking.

  Recruiting at 3 sites Uppsala University · Gothenburg and 3 other locations · NCT07273409

• Personalized mRNA vaccine for advanced endocrine tumors

  This study is testing a personalized mRNA vaccine to see if it can help patients with advanced endocrine tumors who haven't had success with standard treatments.

  Recruiting Shanghai Jiao Tong University School of Medicine · Shanghai, Shanghai Municipality · NCT06141369

• Early detection of pancreatic neuroendocrine tumors using blood tests

  This study is testing a new blood test to see if it can help find pancreatic neuroendocrine tumors earlier than current methods in adults who have not yet received treatment.

  Recruiting at 2 sites Fudan University · Shanghai, Shanghai Municipality and 1 other locations · NCT05847855

• Using chemotherapy after surgery for high-risk pancreatic neuroendocrine tumors

  This study tests if a combination of two chemotherapy drugs can help prevent cancer from coming back in people who have had surgery for high-risk pancreatic neuroendocrine tumors.

  Recruiting at 381 sites Phase 2 SWOG Cancer Research Network · Anchorage, Alaska and 447 other locations · NCT05040360

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.